KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Cash from Operations (2016 - 2025)

Historic Cash from Operations for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to -$147136.0.

  • LifeMD's Cash from Operations fell 10219.67% to -$147136.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year decrease of 4297.07%. This contributed to the annual value of $17.5 million for FY2024, which is 9855.7% up from last year.
  • Per LifeMD's latest filing, its Cash from Operations stood at -$147136.0 for Q3 2025, which was down 10219.67% from $8.6 million recorded in Q2 2025.
  • Over the past 5 years, LifeMD's Cash from Operations peaked at $8.6 million during Q2 2025, and registered a low of -$10.7 million during Q2 2021.
  • In the last 5 years, LifeMD's Cash from Operations had a median value of -$147136.0 in 2025 and averaged -$954027.3.
  • In the last 5 years, LifeMD's Cash from Operations plummeted by 147699.56% in 2021 and then surged by 52236.27% in 2024.
  • Over the past 5 years, LifeMD's Cash from Operations (Quarter) stood at -$5.8 million in 2021, then soared by 66.2% to -$2.0 million in 2022, then surged by 390.17% to $5.7 million in 2023, then plummeted by 81.22% to $1.1 million in 2024, then tumbled by 113.71% to -$147136.0 in 2025.
  • Its last three reported values are -$147136.0 in Q3 2025, $8.6 million for Q2 2025, and $3.1 million during Q1 2025.